596 related articles for article (PubMed ID: 33762736)
1. Auto-aggressive CXCR6
Dudek M; Pfister D; Donakonda S; Filpe P; Schneider A; Laschinger M; Hartmann D; Hüser N; Meiser P; Bayerl F; Inverso D; Wigger J; Sebode M; Öllinger R; Rad R; Hegenbarth S; Anton M; Guillot A; Bowman A; Heide D; Müller F; Ramadori P; Leone V; Garcia-Caceres C; Gruber T; Seifert G; Kabat AM; Mallm JP; Reider S; Effenberger M; Roth S; Billeter AT; Müller-Stich B; Pearce EJ; Koch-Nolte F; Käser R; Tilg H; Thimme R; Boettler T; Tacke F; Dufour JF; Haller D; Murray PJ; Heeren R; Zehn D; Böttcher JP; Heikenwälder M; Knolle PA
Nature; 2021 Apr; 592(7854):444-449. PubMed ID: 33762736
[TBL] [Abstract][Full Text] [Related]
2. NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
Pfister D; Núñez NG; Pinyol R; Govaere O; Pinter M; Szydlowska M; Gupta R; Qiu M; Deczkowska A; Weiner A; Müller F; Sinha A; Friebel E; Engleitner T; Lenggenhager D; Moncsek A; Heide D; Stirm K; Kosla J; Kotsiliti E; Leone V; Dudek M; Yousuf S; Inverso D; Singh I; Teijeiro A; Castet F; Montironi C; Haber PK; Tiniakos D; Bedossa P; Cockell S; Younes R; Vacca M; Marra F; Schattenberg JM; Allison M; Bugianesi E; Ratziu V; Pressiani T; D'Alessio A; Personeni N; Rimassa L; Daly AK; Scheiner B; Pomej K; Kirstein MM; Vogel A; Peck-Radosavljevic M; Hucke F; Finkelmeier F; Waidmann O; Trojan J; Schulze K; Wege H; Koch S; Weinmann A; Bueter M; Rössler F; Siebenhüner A; De Dosso S; Mallm JP; Umansky V; Jugold M; Luedde T; Schietinger A; Schirmacher P; Emu B; Augustin HG; Billeter A; Müller-Stich B; Kikuchi H; Duda DG; Kütting F; Waldschmidt DT; Ebert MP; Rahbari N; Mei HE; Schulz AR; Ringelhan M; Malek N; Spahn S; Bitzer M; Ruiz de Galarreta M; Lujambio A; Dufour JF; Marron TU; Kaseb A; Kudo M; Huang YH; Djouder N; Wolter K; Zender L; Marche PN; Decaens T; Pinato DJ; Rad R; Mertens JC; Weber A; Unger K; Meissner F; Roth S; Jilkova ZM; Claassen M; Anstee QM; Amit I; Knolle P; Becher B; Llovet JM; Heikenwalder M
Nature; 2021 Apr; 592(7854):450-456. PubMed ID: 33762733
[TBL] [Abstract][Full Text] [Related]
3. CD8
Breuer DA; Pacheco MC; Washington MK; Montgomery SA; Hasty AH; Kennedy AJ
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G211-G224. PubMed ID: 31709830
[TBL] [Abstract][Full Text] [Related]
4. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
Zhu H; Zhang Q; Chen G
Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD122 antibody restores specific CD8
Lacotte S; Slits F; Moeckli B; Peloso A; Koenig S; Tihy M; El Hajji S; Gex Q; Rubbia-Brandt L; Toso C
Oncoimmunology; 2023; 12(1):2184991. PubMed ID: 36891258
[TBL] [Abstract][Full Text] [Related]
6. CD8
Koda Y; Teratani T; Chu PS; Hagihara Y; Mikami Y; Harada Y; Tsujikawa H; Miyamoto K; Suzuki T; Taniki N; Sujino T; Sakamoto M; Kanai T; Nakamoto N
Nat Commun; 2021 Jul; 12(1):4474. PubMed ID: 34294714
[TBL] [Abstract][Full Text] [Related]
7. Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis.
Van Herck MA; Vonghia L; Kwanten WJ; Julé Y; Vanwolleghem T; Ebo DG; Michielsen PP; De Man JG; Gama L; De Winter BY; Francque SM
Cell Mol Gastroenterol Hepatol; 2020; 10(3):467-490. PubMed ID: 32360637
[TBL] [Abstract][Full Text] [Related]
8. Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation.
Yahoo N; Dudek M; Knolle P; Heikenwälder M
J Hepatol; 2023 Aug; 79(2):538-551. PubMed ID: 36893854
[TBL] [Abstract][Full Text] [Related]
9.
Li T; Lin X; Shen B; Zhang W; Liu Y; Liu H; Wang Y; Zheng L; Zhi F
Front Immunol; 2022; 13():1047570. PubMed ID: 36531991
[TBL] [Abstract][Full Text] [Related]
10. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.
Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D
FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375
[TBL] [Abstract][Full Text] [Related]
11. Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8
Rein-Fischboeck L; Haberl EM; Bajraktari G; Feder S; Pohl R; Eggenhofer E; Buechler C
Exp Mol Pathol; 2020 Apr; 113():104363. PubMed ID: 31881201
[TBL] [Abstract][Full Text] [Related]
12. CXCR6 is required for antitumor efficacy of intratumoral CD8
Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
[TBL] [Abstract][Full Text] [Related]
13. The function of the chemokine receptor CXCR6 in the T cell response of mice against Listeria monocytogenes.
Heesch K; Raczkowski F; Schumacher V; Hünemörder S; Panzer U; Mittrücker HW
PLoS One; 2014; 9(5):e97701. PubMed ID: 24832098
[TBL] [Abstract][Full Text] [Related]
14. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
15. IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells.
Hydes T; Noll A; Salinas-Riester G; Abuhilal M; Armstrong T; Hamady Z; Primrose J; Takhar A; Walter L; Khakoo SI
Immun Inflamm Dis; 2018 Mar; 6(1):34-46. PubMed ID: 28952190
[TBL] [Abstract][Full Text] [Related]
16. Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling.
Barrow F; Khan S; Fredrickson G; Wang H; Dietsche K; Parthiban P; Robert S; Kaiser T; Winer S; Herman A; Adeyi O; Mouzaki M; Khoruts A; Hogquist KA; Staley C; Winer DA; Revelo XS
Hepatology; 2021 Aug; 74(2):704-722. PubMed ID: 33609303
[TBL] [Abstract][Full Text] [Related]
17. Myeloid cell MHC I expression drives CD8
Adams VR; Collins LB; Williams TI; Holmes J; Hess P; Atkins HM; Scheidemantle G; Liu X; Lodge M; Johnson AJ; Kennedy A
Front Immunol; 2023; 14():1302006. PubMed ID: 38274832
[TBL] [Abstract][Full Text] [Related]
18. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8
Muñoz-Durango N; Arrese M; Hernández A; Jara E; Kalergis AM; Cabrera D
Front Immunol; 2020; 11():563434. PubMed ID: 33391254
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution.
Haas JT; Vonghia L; Mogilenko DA; Verrijken A; Molendi-Coste O; Fleury S; Deprince A; Nikitin A; Woitrain E; Ducrocq-Geoffroy L; Pic S; Derudas B; Dehondt H; Gheeraert C; Van Gaal L; Driessen A; Lefebvre P; Staels B; Francque S; Dombrowicz D
Nat Metab; 2019 Jun; 1(6):604-614. PubMed ID: 31701087
[TBL] [Abstract][Full Text] [Related]
20. Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis Model.
Drori A; Rotnemer-Golinkin D; Zolotarov L; Ilan Y
Digestion; 2017; 96(2):110-118. PubMed ID: 28796993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
